Trial Profile
Study to Compare Immunogenicity of GSK Biologicals' 10Pn-PD-DiT 4-dose Presentation to the Licensed Synflorix (10Pn-PD-DiT) Vaccine When Co-administered With DTPw-combination Vaccine in Healthy Infants
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 22 Jun 2023
Price :
$35
*
At a glance
- Drugs Pneumococcal 10-valent vaccine conjugate (Primary) ; Hib-DTP-hepatitis B vaccine
- Indications Otitis media; Pneumococcal infections; Pneumonia
- Focus Pharmacodynamics; Registrational
- Sponsors GlaxoSmithKline; GSK
- 22 Dec 2017 Primary endpoint (Antibody Concentrations Against Pneumococcal Serotypes (Epoch 001)) has been met, according to the results published in the Vaccine
- 22 Dec 2017 Results published in the Vaccine
- 09 Jun 2016 Status changed from active, no longer recruiting to completed.